{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:13:52Z","timestamp":1765602832653,"version":"3.48.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmech.2025.117653","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:23:38Z","timestamp":1744917818000},"page":"117653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acyclic purine and pyrimidine nucleotide analogs as ecto-5\u2032-nucleotidase (CD73) inhibitors"],"prefix":"10.1016","volume":"294","author":[{"given":"Stephanie","family":"Federico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Renn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Brehova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zlatko","family":"Janeba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Mosch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha Abu","family":"Shamleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helay","family":"Baburi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"El-Tayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Str\u00e4ter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117653_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/med.21302","article-title":"Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase\/phosphodiesterase, Ecto-5\u2032-Nucleotidase, and alkaline phosphatase inhibitors","volume":"34","author":"al-Rashida","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117653_bib2","series-title":"Cellular Function and Molecular Structure of ecto-nucleotidases","first-page":"437","author":"Zimmermann","year":"2012"},{"key":"10.1016\/j.ejmech.2025.117653_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2012.04623.x","article-title":"CD73 and adenosine generation in the creation of regulatory microenvironments","volume":"171","author":"Regateiro","year":"2013","journal-title":"Clin. Exp. Immunol."},{"year":"2014","series-title":"Review Article the Roles of CD73 in Cancer, 2014","author":"Gao","key":"10.1016\/j.ejmech.2025.117653_bib4"},{"key":"10.1016\/j.ejmech.2025.117653_bib5","first-page":"1","article-title":"Blockade of CD73 delays glioblastoma growth by modulating the immune environment","author":"Azambuja","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ejmech.2025.117653_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117653_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2017.11.001","article-title":"Extracellular adenosine produced by ecto-5\u2032-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors salmonella persistence","volume":"72","author":"Costales","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2025.117653_bib8","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-10-1544","article-title":"CD73: a novel target for cancer immunotherapy","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117653_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","article-title":"Targeting cancer-derived adenosine:new therapeutic approaches","volume":"4","author":"Young","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.117653_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/485156","article-title":"CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth","author":"Allard","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117653_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1312044","article-title":"Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases","volume":"6","author":"Vijayan","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejmech.2025.117653_bib12","article-title":"CD73 downregulation decreases in vitro and in vivo glioblastoma growth","author":"Azambuja","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117653_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117033","article-title":"High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells","volume":"177","author":"Giraulo","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117653_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1212209","article-title":"Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy","volume":"14","author":"Kurago","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117653_bib15","article-title":"Blocking CD73 can shrink pancreatic tumors","volume":"11","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.117653_bib16","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.0c00525","article-title":"Discovery of AB680 \u2013 a potent and selective inhibitor of CD73","author":"Lawson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms241411759","article-title":"The clinical significance of CD73 in cancer","volume":"24","author":"Bach","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1 14","key":"10.1016\/j.ejmech.2025.117653_bib18","first-page":"1","article-title":"A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death","volume":"14","author":"Ray","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ejmech.2025.117653_bib19","article-title":"Small molecular CD73 inhibitors: recent progress and future perspectives","volume":"264","author":"Hui Ge","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2174\/0929867322666150408112615","article-title":"Insights into Ecto-5\u2019-Nucleotidase as a new target for cancer therapy: a medicinal chemistry study","volume":"22","author":"Corbelini","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127067","article-title":"Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents","volume":"30","author":"Varano","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117653_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005943","article-title":"Identification of allosteric inhibitors of the ecto-5\u2019-nucleotidase (CD73) targeting the dimer interface","volume":"14","author":"Rahimova","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2025.117653_bib23","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/acsmedchemlett.0c00343","article-title":"Synthesis, characterization, and in silico studies of novel spirooxindole derivatives as Ecto-5\u2032-Nucleotidase inhibitors","volume":"11","author":"Ashraf","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117653_bib24","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1021\/jm300658n","article-title":"Virtual screening identifies novel sulfonamide inhibitors of ecto -5\u2032-Nucleotidase","volume":"55","author":"Ripphausen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib25","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/jm901851t","article-title":"Development of potent and selective inhibitors of ecto-5\u2032- nucleotidase based on an anthraquinone scaffold","volume":"53","author":"Baqi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejmech.2013.10.053","article-title":"Identification of sulfonic acids as efficient ecto-5\u2032-nucleotidase inhibitors","volume":"70","author":"Iqbal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib27","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.str.2012.10.001","article-title":"Crystal structure of the human ecto-5\u2032-nucleotidase (CD73): insights into the regulation of purinergic signaling","volume":"20","author":"Knapp","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.117653_bib28","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.180837","article-title":"Synthesis of novel (E)-1-(2-(2-(4(dimethylamino) benzylidene) hydrazinyl)-4-methylthiazol-5-yl)ethanone derivatives as ecto-5\u2032-nucleotidase inhibitors","volume":"5","author":"Hassan","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.ejmech.2025.117653_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/cbdd.12861","article-title":"Isonicotinohydrazones as inhibitors of alkaline phosphatase and ecto-5\u2032-nucleotidase","volume":"89","author":"Channar","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117653_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acs.jcim.9b00884","article-title":"Virtual screening approach for the identification of hydroxamic acids as novel human Ecto-5\u2032-Nucleotidase inhibitors","volume":"60","author":"Viviani","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.117653_bib31","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/acs.jmedchem.9b01713","article-title":"Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73","volume":"63","author":"Beatty","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1039\/C7OB02729J","article-title":"A domino reaction of 3-chlorochromones with aminoheterocycles. Synthesis of pyrazolopyridines and benzofuropyridines and their optical and ecto-5\u2032-nucleotidase inhibitory effects","volume":"16","author":"Miliutina","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib33","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/acs.jmedchem.9b00164","article-title":"Structure-activity relationship of purine and pyrimidine nucleotides as Ecto-5\u2032-Nucleotidase (CD73) inhibitors","volume":"62","author":"Junker","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib34","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1021\/acs.jmedchem.5b00802","article-title":"\u03b1,\u03b2-Methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective ecto -5\u2032-Nucleotidase (CD73) inhibitors","volume":"58","author":"Bhattarai","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejmech.2018.08.035","article-title":"CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates","volume":"157","author":"Dumontet","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib36","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1021\/acs.jmedchem.1c01852","article-title":"Structure-activity relationship of 3-Methylcytidine-5\u2032-\u03b1,\u03b2-methylenediphosphates as CD73 inhibitors","volume":"65","author":"Scortichini","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcp.2014.11.002","article-title":"Polyoxometalates - Potent and selective ecto-nucleotidase inhibitors","volume":"93","author":"Lee","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117653_bib40","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1158\/1538-7445.AM2018-1756","article-title":"Abstract 1756: discovery and characterization of AB680, a potent and selective small-molecule CD73 inhibitor for cancer immunotherapy","volume":"78","author":"Lawson","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117653_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201900075","article-title":"X\u2010ray co\u2010crystal structure guides the way to subnanomolar competitive Ecto\u20105\u2032\u2010Nucleotidase (CD73) inhibitors for cancer immunotherapy","author":"Bhattarai","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2025.117653_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11302-021-09802-w","article-title":"Substrate binding modes of purine and pyrimidine nucleotides to human ecto-5\u2032-nucleotidase (CD73) and inhibition by their bisphosphonic acid derivatives","volume":"17","author":"Scaletti","year":"2021","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2025.117653_bib43","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cmdc.201900348","article-title":"Synthesis of substituted 5\u2032\u2010Aminoadenosine derivatives and evaluation of their inhibitory potential toward CD73","volume":"14","author":"Ghoteimi","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117653_bib38","article-title":"Drug structures displayed for the first time in Orlando","author":"Nguyen","year":"2019","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.ejmech.2025.117653_bib39","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acs.jmedchem.9b01611","article-title":"2-Substituted \u03b1,\u03b2-Methylene-ADP derivatives: potent competitive Ecto-5\u2032-nucleotidase (CD73) inhibitors with variable binding modes","volume":"63","author":"Bhattarai","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ejoc.200800911","article-title":"Synthesis of analogues of acyclic nucleoside diphosphates containing a (phosphonomethyl)phosphanyl moiety and studies of their phosphorylation","author":"Dol\u00e1kov\u00e1","year":"2009","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ab.2013.10.012","article-title":"A new, sensitive ecto-5\u2032-nucleotidase assay for compound screening","volume":"446","author":"Freundlieb","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117653_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/jps.2600560905","article-title":"Irreversible enzyme inhibitors 98 hydrophobic interactions with succinoadenylate kinosynthetase and 9-substituted adenines","volume":"56","author":"Baker","year":"1967","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117653_bib47","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1021\/bi00801a033","article-title":"Phenylalanyl transfer ribonucleic acid synthetase from escherichia coli. Analysis of the adenosine triphosphate binding site","volume":"10","author":"Santi","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.117653_bib48","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1021\/jm051146h","article-title":"7\u2032-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors","volume":"49","author":"Zhang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11302-007-9068-9","article-title":"New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile","volume":"3","author":"Lambertucci","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2025.117653_bib50","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.bmc.2009.05.062","article-title":"Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y2receptor antagonists","volume":"17","author":"Sauer","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/op800284k","article-title":"Practical synthesis of roscovitine and CR8","volume":"13","author":"Oumata","year":"2009","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2025.117653_bib52","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1021\/jo000983i","article-title":"Synthesis of tert -Butoxycarbonyl (Boc)-Protected purines","volume":"65","author":"Dey","year":"2000","journal-title":"J. Org. Chem."},{"year":"2002","series-title":"Synthesis of Combretastatin A-2 Prodrugs, US 7105695","author":"Pettit","key":"10.1016\/j.ejmech.2025.117653_bib53"},{"key":"10.1016\/j.ejmech.2025.117653_bib54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0960-894X(00)80413-8","article-title":"Carbocyclic phosphonate analogs of 2\u2032,3\u2032-dideoxyadenosine-5\u2032-monophosphate as substrates of 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetate","volume":"2","author":"Nav\u00e9","year":"1992","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117653_bib55","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/ejic.200300100","article-title":"Solution structures of binary and ternary metal ion complexes of 9-(5-Phosphonopentyl)adenine (3\u2032-deoxa-PEEA). A nucleotide analogue related to the antivirally active 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA)","volume":"2003","author":"G\u00f3mez-Coca","year":"2003","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib56","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1021\/jo00103a010","article-title":"AMP deaminase as a novel practical catalyst in the synthesis of 6-Oxopurine ribosides and their analogs","volume":"59","author":"Margolin","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib57","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/0006-2952(90)90087-2","article-title":"5\u2019-Deoxy-5\u2019-methylthioadenosine phosphorylase\u2014V","volume":"40","author":"Savarese","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117653_bib58","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1002\/anie.201001928","article-title":"Vitamin B12 mimics having a peptide backbone and tuneable coordination and redox properties","volume":"49","author":"Zhou","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117653_bib59","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/ejoc.200901372","article-title":"Broadening the synthetic scope of the iron(III)-Catalyzed aza-prins cyclization","author":"Carballo","year":"2010","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1098-2299(199811\/12)45:3\/4<269::AID-DDR25>3.0.CO;2-B","article-title":"Catalytically active soluble ecto-5\u2019-nucleotidase purified after heterologous expression as a tool for drug screening","volume":"45","author":"Servos","year":"1998","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.117653_bib61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5\u2019-Nucleotidase: molecular structure and functional aspects","volume":"285","author":"Zimmermann","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117653_bib62","article-title":"The role of the phosphorus atom in drug design","volume":"14","author":"Rodriguez","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117653_bib63","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a luoro-2\u2032-\u03b2- C -methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib65","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/jm9003297","article-title":"High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors","volume":"52","author":"Baqi","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117653_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129464","article-title":"Synthesis and biological evaluation of simplified ajudazol derivatives reveal potent 5-lipoxygenase inhibition and considerable apoptotic activity in neuroblastoma cells","volume":"94","author":"Wollnitzke","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117653_bib67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117653_bib68","doi-asserted-by":"crossref","DOI":"10.1107\/S010876731809640X","article-title":"Advances in automated data analysis and processing within autoPROC , combined with improved characterisation, mitigation and visualisation of the anisotropy of diffraction limits using STARANISO","volume":"74","author":"Vonrhein","year":"2018","journal-title":"Acta Crystallogr. A Found Adv."},{"key":"10.1016\/j.ejmech.2025.117653_bib69","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1093\/bioinformatics\/btr535","article-title":"ISPyB: an information management system for synchrotron macromolecular crystallography","volume":"27","author":"Delageni\u00e8re","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.117653_bib70","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117653_bib71","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.117653_bib72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117653_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abio.1999.4100","article-title":"A robotics-based automated assay for inorganic and organic phosphates","volume":"271","author":"Cogan","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117653_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-4165(96)00079-7","article-title":"Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques","volume":"1334","author":"S\u00e9vigny","year":"1997","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2025.117653_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bph.12135","article-title":"8-BuS-ATP derivatives as specific NTPDase1 inhibitors","volume":"169","author":"Lecka","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117653_bib76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","article-title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","volume":"1","author":"Kukulski","year":"2005","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2025.117653_bib77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/ajpgi.00293.2006","article-title":"Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8","volume":"292","author":"Fausther","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:11:14Z","timestamp":1765602674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":76,"alternative-id":["S0223523425004180"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117653","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acyclic purine and pyrimidine nucleotide analogs as ecto-5\u2032-nucleotidase (CD73) inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117653"}}